Large dataset enables prediction of repair after CRISPR-Cas9 editing in primary T cells.


Journal

Nature biotechnology
ISSN: 1546-1696
Titre abrégé: Nat Biotechnol
Pays: United States
ID NLM: 9604648

Informations de publication

Date de publication:
09 2019
Historique:
received: 19 10 2018
accepted: 27 06 2019
pubmed: 31 7 2019
medline: 7 11 2019
entrez: 31 7 2019
Statut: ppublish

Résumé

Understanding of repair outcomes after Cas9-induced DNA cleavage is still limited, especially in primary human cells. We sequence repair outcomes at 1,656 on-target genomic sites in primary human T cells and use these data to train a machine learning model, which we have called CRISPR Repair Outcome (SPROUT). SPROUT accurately predicts the length, probability and sequence of nucleotide insertions and deletions, and will facilitate design of SpCas9 guide RNAs in therapeutically important primary human cells.

Identifiants

pubmed: 31359007
doi: 10.1038/s41587-019-0203-2
pii: 10.1038/s41587-019-0203-2
pmc: PMC7388783
mid: NIHMS1577182
doi:

Substances chimiques

RNA, Guide 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1034-1037

Subventions

Organisme : NIA NIH HHS
ID : P30 AG059307
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI135990
Pays : United States
Organisme : NIAID NIH HHS
ID : K22 AI136691
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG008164
Pays : United States
Organisme : NIGMS NIH HHS
ID : P50 GM082250
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA209891
Pays : United States
Organisme : NIAID NIH HHS
ID : P50 AI150476
Pays : United States
Organisme : NIDA NIH HHS
ID : DP2 DA042423
Pays : United States

Références

Fischbach, M. A., Bluestone, J. A. & Lim, W. A. Sci. Transl. Med. 5, 179ps7 (2013).
doi: 10.1126/scitranslmed.3005568
Simeonov, D. et al. Commun. Biol. 2, 70 (2019).
doi: 10.1038/s42003-019-0321-x
Hultquist, J. F. et al. Nat. Protoc. 14, 1–27 (2019).
doi: 10.1038/s41596-018-0069-7
Lindsay, H. et al. Nat. Biotechnol. 34, 701–702 (2016).
doi: 10.1038/nbt.3628
van Overbeek, M. et al. Mol. Cell 63, 633–646 (2016).
doi: 10.1016/j.molcel.2016.06.037
Brinkman, E. K. et al. Mol. Cell 70, 801–813 (2018).
doi: 10.1016/j.molcel.2018.04.016
Lemos, B. R. et al. Proc. Natl Acad. Sci. USA 115, E2040–E2047 (2018).
doi: 10.1073/pnas.1716855115
Deriano, L. & Roth, D. B. Annu. Rev. Genet. 47, 433–455 (2013).
doi: 10.1146/annurev-genet-110711-155540
Shen, M. W. et al. Nature 563, 646–651 (2018).
doi: 10.1038/s41586-018-0686-x
Allen, F.et al. Nat. Biotechnol. 37, 64–72 (2019).
Shin, H. Y. et al. Nat. Commun. 8, 15464 (2017).
doi: 10.1038/ncomms15464
Kosicki, M., Tomberg, K. & Bradley, A. Nat. Biotechnol. 36, 765–771 (2018).
doi: 10.1038/nbt.4192
Roth, T. L. et al. Nature 559, 405–409 (2018).
doi: 10.1038/s41586-018-0326-5
Simeonov, D. & Marson, A. Annu. Rev. Immunol. 37, 571–597 (2019).
doi: 10.1146/annurev-immunol-042718-041522
Untergasser, A. et al. Nucleic Acids Res. 40, e115 (2012).
doi: 10.1093/nar/gks596
Magoč, T. & Salzberg, S. L. Bioinformatics 27, 2957–2963 (2011).
doi: 10.1093/bioinformatics/btr507
Bolger, A. M., Lohse, M. & Usadel, B. Bioinformatics 30, 2114–2120 (2014).
doi: 10.1093/bioinformatics/btu170
Li, H. & Durbin, R. Bioinformatics 25, 1754–1760 (2009).
doi: 10.1093/bioinformatics/btp324

Auteurs

Ryan T Leenay (RT)

Chan-Zuckerberg Biohub, San Francisco, CA, USA.

Amirali Aghazadeh (A)

Department of Electrical Engineering, Stanford University, Stanford, CA, USA.

Joseph Hiatt (J)

Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA, USA.
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
Diabetes Center, University of California, San Francisco, San Francisco, CA, USA.
Medical Scientist Training Program, University of California, San Francisco, San Francisco, CA, USA.
J. David Gladstone Institutes, San Francisco, CA, USA.

David Tse (D)

Department of Electrical Engineering, Stanford University, Stanford, CA, USA.

Theodore L Roth (TL)

Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.

Ryan Apathy (R)

Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.

Eric Shifrut (E)

Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.

Judd F Hultquist (JF)

J. David Gladstone Institutes, San Francisco, CA, USA.
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA.
Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Nevan Krogan (N)

J. David Gladstone Institutes, San Francisco, CA, USA.
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
Quantitative Biosciences Institute (QBI), University of California, San Francisco, San Francisco, CA, USA.

Zhenqin Wu (Z)

Department of Chemistry, Stanford University, Stanford, CA, USA.

Giana Cirolia (G)

Chan-Zuckerberg Biohub, San Francisco, CA, USA.

Hera Canaj (H)

Chan-Zuckerberg Biohub, San Francisco, CA, USA.

Manuel D Leonetti (MD)

Chan-Zuckerberg Biohub, San Francisco, CA, USA.

Alexander Marson (A)

Chan-Zuckerberg Biohub, San Francisco, CA, USA. alexander.marson@ucsf.edu.
Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.
Diabetes Center, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.
Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA. alexander.marson@ucsf.edu.
Department of Medicine, University of California, San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. alexander.marson@ucsf.edu.

Andrew P May (AP)

Chan-Zuckerberg Biohub, San Francisco, CA, USA. apmay1@gmail.com.
Sana Biotechnology, South San Francisco, CA, USA. apmay1@gmail.com.

James Zou (J)

Chan-Zuckerberg Biohub, San Francisco, CA, USA. jamesz@stanford.edu.
Department of Electrical Engineering, Stanford University, Stanford, CA, USA. jamesz@stanford.edu.
Department of Biomedical Data Science, Stanford University, Stanford, CA, USA. jamesz@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH